Vickie & Jack Farber
Shortcodes Ultimate
Discovery and innovation
Current Research
Wills Eye is harnessing the power and possibility of technology to transform data and information into knowledge that can improve patient outcomes and advance the delivery of eye care.
Wills Eye Hospital invites patients and the community to participate in innovative clinical trials and research studies.
An international team of thought leaders with a wide range of expertise in and outside ophthalmology examine new pathways and potentially transformational technology to advance eyecare and fight vision loss.
Clinical Research Areas
Within each subspecialty of ophthalmology, researchers at Wills Eye are studying disease characteristics and examining effectiveness and clinical outcomes for surgical and drug treatments for a wide range of common and rare ocular diseases including leading causes of vision impairment such as glaucoma, corneal conditions, diabetic retinopathy, age-related macular degeneration and ocular cancers.
Glaucoma
Glaucoma research at Wills Eye includes pharmacologic advancements in the treatment of glaucoma and surgical interventions to minimize risk and improve outcomes of glaucoma surgery, including the use of new and novel surgical devices.
Diabetic Retinopathy
Diabetic retinopathy, a complication of diabetes, affects the eyes by causing deterioration of blood vessels in the retina. Wills Eye retina doctors are leading experts in the treatment of diabetic retinopathy with the latest clinical trials and new therapeutic approaches for this disease.
Macular Degeneration
Macular degeneration refers to the age-related degenerative changes in the retina that can result in loss of central vision. Wills Eye Retina specialists are in the forefront of research efforts, participating in multiple clinical trials to investigate new and emerging forms of treatment for AMD.
Researchers • clinician scientists • educators
Research Leadership
